secwatch.observer — SEC 8-K summary
======================================

Issuer:     Summit Therapeutics Inc. (SMMT)
CIK:        0001599298
Form:       8-K
Filed at:   2025-10-22T23:59:59+00:00
Accession:  0001193125-25-245790
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Summit Therapeutics raises $500M in private placement at $18.74/share; insiders invest $282M
--------------------------------------------------------------------------------

- Raised $500M gross and net proceeds from sale of 26.68M shares at $18.74 each, the closing price on Oct 21, 2025.
- Insiders including Duggan, Zanganeh, Soni, Anand contributed $272M; Akeso added $10M, total insider investment $282M.
- Proceeds will fund clinical development of ivonescimab and general corporate purposes.
- Closing expected on or before October 28, 2025, subject to customary conditions.
- Shares issued in a private placement exempt from registration; resale registration to be filed by Dec 19, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1599298/000119312525245790/0001193125-25-245790-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1599298/000119312525245790/d274712d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-245790

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer